Pular para o conteúdo principal

CLN1 disease

CLN1 disease is an inherited disorder that primarily affects the nervous system. Individuals with this condition have normal development in infancy, but typically by 18 months they become increasingly irritable and begin to lose previously acquired skills (developmental regression). In affected children, nerve cells in the brain die over time, leading to an overall loss of brain tissue (brain atrophy) and an unusually small head (microcephaly). Children with CLN1 disease have decreased muscle tone (hypotonia), intellectual and motor disability, and rarely are able to speak or walk. Some affected children develop repetitive hand movements. By age 2, individuals with this condition often have muscle twitches (myoclonus), recurrent seizures (epilepsy), and vision loss. Some affected children develop frequent respiratory infections. As the condition worsens, children have severe feeding difficulties that often require a feeding tube. Children with CLN1 disease usually do not survive past childhood.

Descrição

CLN1 disease is an inherited disorder that primarily affects the nervous system. Individuals with this condition have normal development in infancy, but typically by 18 months they become increasingly irritable and begin to lose previously acquired skills (developmental regression). In affected children, nerve cells in the brain die over time, leading to an overall loss of brain tissue (brain atrophy) and an unusually small head (microcephaly). Children with CLN1 disease have decreased muscle tone (hypotonia), intellectual and motor disability, and rarely are able to speak or walk. Some affected children develop repetitive hand movements. By age 2, individuals with this condition often have muscle twitches (myoclonus), recurrent seizures (epilepsy), and vision loss. Some affected children develop frequent respiratory infections. As the condition worsens, children have severe feeding difficulties that often require a feeding tube. Children with CLN1 disease usually do not survive past childhood.

Some people with CLN1 disease do not develop symptoms until later in childhood or in adulthood. As with younger affected children, older individuals develop a decline in intellectual function, myoclonus, epilepsy, and vision loss. In these individuals, life expectancy depends on when signs and symptoms of CLN1 disease develop and their severity; affected individuals may survive only into adolescence or through adulthood. Adults with CLN1 disease may also have movement disorders, including impaired muscle coordination (ataxia) or a pattern of movement abnormalities known as parkinsonism.

CLN1 disease is one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), which may also be collectively referred to as Batten disease. All these disorders affect the nervous system and typically cause worsening problems with vision, movement, and thinking ability. The different NCLs are distinguished by their genetic cause. Each disease type is given the designation "CLN," meaning ceroid lipofuscinosis, neuronal, and then a number to indicate its subtype.

Padrões de herança

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Other names

CLN1

Infantile Batten disease

Infantile neuronal ceroid lipofuscinosis

Neuronal ceroid lipofuscinosis 1

Neuronal ceroid lipofuscinosis, infantile

Santavuori-Haltia disease

Related patient information and medicines

Doença renal crônica

Patient information leaflet

Doença renal crônica

Chronic kidney disease means that the kidneys are not working as well as would be expected. Various conditions can cause chronic kidney disease. Severity can vary but most cases are mild or moderate, occur in older people and do not cause sy... What is chronic kidney disease. Chronic kidney disease (CKD) means that the kidneys are not working as.

Avaliação do risco de saúde cardiovascular

Patient information leaflet

Avaliação do risco de saúde cardiovascular

Conditions that increase the risk of CVD include hypertension High blood pressure , diabetes mellitus Diabetes , chronic kidney disease Chronic kidney disease , high lipids High cholesterol , rheumatoid arthritis Rheumatoid arthritis , influenza Flu , serious mental health problems, and periodontitis (gum disease). People with type 1 diabetes.

Doença de Crohn

Patient information leaflet

Doença de Crohn

Crohn's disease is a condition that causes inflammation of the wall of the gut (gastrointestinal tract). Any part of the gut can be affected. What is Crohn's disease. Having an episode of gastroenteritis Gastroenteritis (risk is associated with the fir... How common is Crohn's disease. Crohn's disease is newly diagnosed in about 1 in 10,000 people.

Doença renal diabética

Patient information leaflet

Doença renal diabética

Doença renal diabética is a complication that occurs in some pessoas com diabetes. Treatment aims to prevent or delay the progression of the disease. Diabetic kidney disease (diabetic nephropathy) is a complication that occurs in some people with diabetes. Diabetic kidney disease is one of the causes of chronic kidney disease Chronic kidney.

Doenças relacionadas ao amianto

Patient information leaflet

Doenças relacionadas ao amianto

People exposed to asbestos can develop diseases in later life. These most commonly affect the lungs but can also affect the lining of the tummy (abdomen). Some conditions - for example, mesothelioma or lung cancer - are more serious than others. This leaflet gives a brief overview of the diseases that are related to having an exposure to asbestos.

Doença inflamatória intestinal

Patient information leaflet

Doença inflamatória intestinal

Inflammatory Bowel Disease (IBD) is a term used to describe people who either have either of the two main types of IBD (Crohn's disease e ulcerative colitis). Both these conditions can cause inflammation of the colon and rectum (large bowel or large intestine) with similar symptoms, such as bloody diarrhoea, tummy (abdominal) pain, weight loss.

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.
  • 3 Apr 2025 | Última versão
  • 1 Oct 2016 | Publicado originalmente

Participe da conversa

Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.

Aviso: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmácia online, tratamentos e serviços de saúde

Acesso simples a tratamentos confiáveis e serviços de saúde online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscreva-se no boletim informativo do Patient

Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.